Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep-Oct;60(5):519.
doi: 10.4103/0019-5154.159633.

Erythromycin as a Safe and Effective Treatment Option for Erythema Annulare Centrifugum

Fu-Chen Chuang  1 , Shang-Hong Lin  1 , Wei-Ming Wu  1
Affiliations

Erythromycin as a Safe and Effective Treatment Option for Erythema Annulare Centrifugum

Fu-Chen Chuang et al. Indian J Dermatol. 2015 Sep-Oct.

Abstract

Background: Erythema annulare centrifugum (EAC) is an inflammatory dermatosis with unknown etiology. It is usually self-limited, but chronic disease may be difficult to treat. We observed incidentally the therapeutic effect of erythromycin for EAC among patients taking erythromycin for other diseases.

Aim: To evaluate the treatment response of erythromycin for EAC.

Materials and methods: During the study period, from July 2007 to February 2011, all patients with EAC were assigned to erythromycin stearate tablet 1000 mg per day for two weeks. EAC was diagnosed by a constellation of clinical and pathological findings. The efficacy (before and after the treatment) was assessed clinically by one dermatologist and photographically by two blinded dermatologists. Secondary outcomes included adverse drug effects and recurrence.

Results: Eight patients were enrolled in this study. Most patients had chronic relapsing disease with poor response to previous treatment. All the patients showed rapid response with profound reduction in the size of lesion and erythema two weeks after initiation of erythromycin treatment. The response was so obvious and complete that a coincidental response was less likely. Three patients had recurrence of disease and they tended to have more extensive lesions. Readministration of erythromycin was effective. All patients tolerated the treatment well.

Conclusion: Our study documented erythromycin as a safe and cost-effective treatment for EAC.

Keywords: Erythema annulare centrifugum; erythromycin; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Photographs taken before (a) and after a two-week treatment (b) with erythromycin for the arm lesion of patient 4
Figure 2
Figure 2
Photographs taken before (a) and after a two-week treatment (b) with erythromycin for the leg lesion of patient 6
See this image and copyright information in PMC

References

    1. Bottoni U, Innocenzi D, Bonaccorsi P, Carlesimo M, Faina P, Richetta A, et al. Erythema annulare centrifugum: Report of a case with neonatal onset. J Eur Acad Dermatol Venereol. 2002;16:500–3. - PubMed
    1. Bressler GS, Jones RE., Jr Erythema annulare centrifugum. J Am Acad Dermatol. 1981;4:597–602. - PubMed
    1. Kim KJ, Chang SE, Choi JH, Sung KJ, Moon KC, Koh JK. Clinicopathologic analysis of 66 cases of erythema annulare centrifugum. J Dermatol. 2002;29:61–7. - PubMed
    1. Weyers W, Diaz-Cascajo C, Weyers I. Erythema annulare centrifugum: Results of a clinicopathologic study of 73 patients. Am J Dermatopathol. 2003;25:451–62. - PubMed
    1. Ibrahim SF, Pryor J, Tausk FA. Stress-induced erythema annulare centrifugum. Dermatol Online J. 2009;15:15. - PubMed

LinkOut - more resources